Practical Issues in Clinical Inspection Process.

Published

Journal Article

Regulatory inspection of clinical trial is necessary in order for (1) assessing compliance with statutory requirements and regulatory requirement governing the conduct of clinical trials and (2) verifying the accuracy and reliability of clinical trial data submitted to regulatory agencies such as the United States Food and Drug Administration (FDA) in support of research or marketing applications. This article provides an overview of clinical inspection process and issues that are commonly encountered during the conduct of clinical trials. In addition, a couple of sampling plans for clinical inspection of relatively large trials are proposed. The proposed statistical process for clinical inspection that will achieve a desired degree of inspection accuracy and reliability is useful when the resources of inspectors are limited. The proposed 2-stage sampling plan can be applied to clinical inspection for multicenter and/or multinational multicenter clinical trials.

Full Text

Duke Authors

Cited Authors

  • Song, F; Qian, X; Li, J; Chow, S-C; Hong, M

Published Date

  • May 2019

Published In

Volume / Issue

  • 53 / 3

Start / End Page

  • 374 - 380

PubMed ID

  • 29909649

Pubmed Central ID

  • 29909649

Electronic International Standard Serial Number (EISSN)

  • 2168-4804

Digital Object Identifier (DOI)

  • 10.1177/2168479018769887

Language

  • eng

Conference Location

  • United States